page contents

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Jan 11, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX)

Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX).

There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Agile Therapeutics Inc (NASDAQ:AGRX) is Buy with a consens…
Nasdaq Search Results

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close